Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Glioma, melatonin, and radiotherapy [PMID: 16778225] Laboratory literature summary: Glioma, melatonin, and radiotherapy
Toxicol Appl Pharmacol 244(1):6676 Lastres-Becker I, Ulusoy A, Innamorato NG, Sahin G, Rabano A, Kirik D and Cuadrado A (2012) alpha-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinsons disease
Quaas AM, Hansen KR
In several multi-center longitudinal studies involving hemodialysis cohorts, the administration of IV Levocarnitine demonstrated a significant reduction in the ESA Resistance Index. Numerical data from recent trials indicates: Anemia Management: Patients receiving IV Levocarnitine showed an average 15% to 25% reduction in the required dose of Erythropoietin (EPO) to maintain target hemoglobin levels
US$ 26.72
US$ 26.25
US$ 25.39
US$ 21.72
US$ 29.73
US$ 26.50
US$ 25.06
US$ 28.90
US$ 27.37
US$ 22.23
